Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 986 active Lung Cancer trials
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
Study Type: Interventional Phase 2
A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
Study Type: Interventional Phase 1
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
Study Type: Interventional Phase 1
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Study Type: Observational
FDG PET/CT in Lung Cancer Staging
Study Type: Interventional
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
Study Type: Interventional Phase 2
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy
Study Type: Interventional
There are 986 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now